RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

No results found for given criteria.

Related Reports

Market Research Reports provided by reports.iptechex.com
Vertex’s VX770 Is Poised To Become The First Targeted Therapy To Be Approved In Cystic Fibrosis
Mar 2011 - 4 pages - $500
Liver Fibrosis Global Clinical Trials Review, Q1, 2011
Apr 2011 - 57 pages - $1,000
Accura Animal Health Plc (ACPO) - Strategic SWOT Analysis Review
May 2011 - 15 pages - $250
Liver Fibrosis Global Clinical Trials Review, H2, 2011
Sep 2011 - 83 pages - $1,000
Marien-Hospital Wesel GmbH - Strategic SWOT Analysis Review
May 2011 - 15 pages - $250
Animal Health Products Antibacterials Markets
May 2008 - 70 pages - $1,999
Cystic Fibrosis Global Clinical Trials Review, Q2, 2011
Jun 2011 - 74 pages - $1,000
Union Memorial Hospital - Strategic SWOT Analysis Review
May 2011 - 15 pages - $250
Accura Animal Health Plc (ACPO) - Financial and Strategic Analysis Review
Oct 2010 - 25 pages - $250
ECO Animal Health Group plc (EAH) - Financial and Strategic SWOT Analysis Review
May 2011 - 25 pages - $125
More Related Market Research Reports >>>

Your selection

Industry sector
Animal health del
Pharmaceutical del
Therapeutic target
Hospital and Surgery del
Fibrosis del
Development phase
Registered del

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us